Ignite Creation Date:
2025-12-24 @ 10:18 PM
Ignite Modification Date:
2025-12-25 @ 7:51 PM
Study NCT ID:
NCT00560235
Status:
COMPLETED
Last Update Posted:
2015-10-28
First Post:
2007-11-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
Sponsor:
Pfizer
Organization:
Study Overview
Official Title:
A Phase 1/Phase 2 Study Of CP-751,871 In Patients With Relapsed And/Or Refractory Ewing's Sarcoma Family Of Tumors
Status:
COMPLETED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Define the efficacy of CP-751,871 in patients with Ewing's sarcoma family of tumors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: